BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 10834863)

  • 1. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
    Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
    Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
    Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
    BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
    Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
    J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
    Rheumatology (Oxford); 2002 Jan; 41(1):78-87. PubMed ID: 11792884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.
    Tchetverikov I; Ronday HK; Van El B; Kiers GH; Verzijl N; TeKoppele JM; Huizinga TW; DeGroot J; Hanemaaijer R
    Ann Rheum Dis; 2004 Jul; 63(7):881-3. PubMed ID: 15194590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis.
    Kim KS; Choi HM; Lee YA; Choi IA; Lee SH; Hong SJ; Yang HI; Yoo MC
    Rheumatol Int; 2011 Apr; 31(4):543-7. PubMed ID: 20665024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix Metalloproteinase-9 Level in Synovial Fluid-Association with Joint Destruction in Early Rheumatoid Arthritis.
    Stojanovic SK; Stamenkovic BN; Cvetkovic JM; Zivkovic VG; Apostolovic MRA
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products.
    DeGroot J; Verzijl N; Wenting-Van Wijk MJ; Bank RA; Lafeber FP; Bijlsma JW; TeKoppele JM
    Arthritis Rheum; 2001 Nov; 44(11):2562-71. PubMed ID: 11710713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
    Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
    Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10.
    Tolboom TC; Pieterman E; van der Laan WH; Toes RE; Huidekoper AL; Nelissen RG; Breedveld FC; Huizinga TW
    Ann Rheum Dis; 2002 Nov; 61(11):975-80. PubMed ID: 12379519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Oguchi T; Kojima T; Iwata H; Ionescu M; Poole AR
    Arthritis Rheum; 2001 Nov; 44(11):2503-11. PubMed ID: 11710706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis.
    Yoshihara Y; Obata K; Fujimoto N; Yamashita K; Hayakawa T; Shimmei M
    Arthritis Rheum; 1995 Jul; 38(7):969-75. PubMed ID: 7612046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
    Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
    J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of tumor necrosis factor-α (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.
    Stojanovic S; Bojana Stamenkovic ; Stoimenov TJ; Nedovic J; Zivkovic V; Despotovic M; Pavlovic D
    Clin Rheumatol; 2017 Jul; 36(7):1479-1485. PubMed ID: 28573370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease.
    Kubota E; Kubota T; Matsumoto J; Shibata T; Murakami KI
    J Oral Maxillofac Surg; 1998 Feb; 56(2):192-8. PubMed ID: 9461144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.
    Smeets TJ; Barg EC; Kraan MC; Smith MD; Breedveld FC; Tak PP
    Ann Rheum Dis; 2003 Jul; 62(7):635-8. PubMed ID: 12810425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.